Zenta Seto
Toyama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Pre-treatment NLR and Changes in NLR Are Associated With Survival Following the Initiation of Immune Checkpoint Inhibitor Therapy in Patients With Non-small Cell Lung Cancer.
Journal: Cancer diagnosis & prognosis
Published: January 06, 2026
TTF-1 expression is associated with survival in patients with non-squamous non-small cell lung cancer treated with immune checkpoint inhibitor therapy.
Journal: Molecular and clinical oncology
Published: July 08, 2025
TGFβ1 and SMAD3 Expression Are Associated With Survival After the Immune Checkpoint Inhibitor Therapy for Small Cell Lung Cancer.
Journal: Cancer reports (Hoboken, N.J.)
Published: February 26, 2025
Multicenter Retrospective Analysis of Pulmonary Sarcomatoid Carcinoma Clinically Diagnosed Using Small Biopsy Specimens.
Journal: Cancer diagnosis & prognosis
Published: February 20, 2025
Effectiveness of Chemoimmunotherapy in Small-cell Lung Cancer Patients With a Poor Performance Status or Higher Neutrophil/Lymphocyte Ratio.
Journal: In vivo (Athens, Greece)
Published: October 23, 2024
Pure Red Cell Aplasia and Chromosomal Abnormality in a Patient With Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors: A Case Report.
Journal: In vivo (Athens, Greece)
Published: February 08, 2024
Comparison of the efficacy of first‑/second‑generation EGFR‑tyrosine kinase inhibitors and osimertinib for EGFR‑mutant lung cancer with negative or low PD‑L1 expression.
Journal: Molecular and clinical oncology
Published: January 13, 2024
An observational study on the efficacy of targeted therapy for pulmonary sarcomatoid carcinoma.
Journal: Discover oncology
Published: November 30, 2023
Immune Checkpoint Inhibitor Therapy for Patients With Non-small Cell Lung Cancer Ineligible for Platinum Doublet Chemotherapy.
Journal: Anticancer research
Published: October 05, 2023
Association Between the Severity of Immune-related Adverse Events and the Prognosis in Patients With Non-small Cell Lung Cancer Receiving Treatment With Immune Checkpoint Inhibitors.
Journal: Anticancer research
Published: April 13, 2023
Peripheral CD4 memory T cells predict the efficacy of immune checkpoint inhibitor therapy in patients with non-small cell lung cancer.
Journal: Scientific reports
Published: March 06, 2023
Last Updated: 09/26/2026